[HTML][HTML] Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
M Lange, F Joly, J Vardy, T Ahles, M Dubois, L Tron… - Annals of …, 2019 - Elsevier
Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …
significantly increased the chance of survival of cancer patients, even those with metastatic …
Long-term cognitive dysfunction in cancer survivors
Cancer-related cognitive impairment (CRCI) is a frequent side effect experienced by an
increasing number of cancer survivors with a significant impact on their quality of life …
increasing number of cancer survivors with a significant impact on their quality of life …
Gut microbiota-derived short-chain fatty acids: impact on cancer treatment response and toxicities
The gut microbiota has emerged as a key modulator of cancer treatment responses in terms
of both efficacy and toxicity. This effect is clearly mediated by processes impacting the …
of both efficacy and toxicity. This effect is clearly mediated by processes impacting the …
Long-term fatigue and cognitive disorders in breast cancer survivors
Survivors of early-stage breast cancer may report treatment-related side effects that persist
for several years after the end of primary treatment. Among these, fatigue and cognitive …
for several years after the end of primary treatment. Among these, fatigue and cognitive …
Measuring self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group
Cancer and its treatments are associated with increased risk for cancer-related cognitive
impairment (CRCI). Methods and measures used to study and assess self-reported CRCI (sr …
impairment (CRCI). Methods and measures used to study and assess self-reported CRCI (sr …
Patient-reported cognitive impairment among women with early breast cancer randomly assigned to endocrine therapy alone versus chemoendocrine therapy: results …
PURPOSE Cancer-related cognitive impairment (CRCI) is common during adjuvant
chemotherapy and may persist. TAILORx provided a novel opportunity to prospectively …
chemotherapy and may persist. TAILORx provided a novel opportunity to prospectively …
Pretreatment systemic inflammation response index in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator
Background and Objective Systemic inflammation response index (SIRI= N× M/L), based on
neutrophil (N), monocyte (M), and lymphocyte (L) counts, is used to predict the survival of …
neutrophil (N), monocyte (M), and lymphocyte (L) counts, is used to predict the survival of …
Pathogenesis, assessments, and management of chemotherapy‐related cognitive impairment (CRCI): an updated literature review
L Lv, S Mao, H Dong, P Hu, R Dong - Journal of oncology, 2020 - Wiley Online Library
There are various cancer treatments at present, and chemotherapy is one of the main
methods. Chemotherapy‐related cognitive impairment (CRCI), as one of the side effects of …
methods. Chemotherapy‐related cognitive impairment (CRCI), as one of the side effects of …
Neurological complications of conventional and novel anticancer treatments
Simple Summary Cancer survivors can experience neurological complications after
exposure to anticancer therapy. Chemotherapy-induced peripheral neurotoxicity (CIPN) …
exposure to anticancer therapy. Chemotherapy-induced peripheral neurotoxicity (CIPN) …
[HTML][HTML] Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
Z Yao, H Dong, J Zhu, L Du, Y Luo, Q Liu, S Liu, Y Lin… - JCI insight, 2023 - ncbi.nlm.nih.gov
Chemotherapy-related cognitive impairment (CRCI) or “chemo brain” is a devastating
neurotoxic sequela of cancer-related treatments, especially for the elderly individuals. Here …
neurotoxic sequela of cancer-related treatments, especially for the elderly individuals. Here …